Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002100121-26-000070
Filing Date
2026-04-28
Accepted
2026-04-28 15:52:36
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5587
  Complete submission text file 0002100121-26-000070.txt   7394
Mailing Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588
Business Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 (925) 401-7300
10x Genomics, Inc. (Subject) CIK: 0001770787 (see all company filings)

EIN.: 455614458 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91164 | Film No.: 26907321
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 VANGUARD BLVD MALVERN PA 19355
Business Address 100 VANGUARD BLVD MALVERN PA 19355 610-669-6148
VANGUARD PORTFOLIO MANAGEMENT LLC (Filed by) CIK: 0002100121 (see all company filings)

EIN.: 392888838 | State of Incorp.: PA | Fiscal Year End: 1231
LEI: 529900YN99W7NU4H6B84
Type: SCHEDULE 13G